{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:23:29Z","timestamp":1773919409026,"version":"3.50.1"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:p>In childhood, Hodgkin disease (HD) has an excellent outcome in developed countries. There are few studies on outcomes of HD from resource<jats:italic toggle=\"yes\">-<\/jats:italic>limited countries. This study aimed to assess clinical outcomes and factors associated with survival rates of childhood HD in a tertiary care center in Thailand. We retrospectively reviewed the medical records of pediatric HD patients between March 1985 and August 2017. Seventy-two children diagnosed with HD were identified. Pretreatment clinical and laboratory factors were assessed by Cox regression analysis to predict event-free survival (EFS) and overall survival (OS). The overall 5-year EFS and OS rate was 70.7% and 75.5%, respectively. Multivariate analysis identified 3 factors predicting inferior EFS: high-risk group (stages III-B, IV-B), splenomegaly, and platelet count &gt;400,000\/\u00b5L. The prognostic markers were assigned a score of 1 for each factor. For a total score of 0, the 5-year EFS and OS rates were 95% and 86%; scores 2 to 3, 33% and 54%, respectively. In conclusion, our study identified 3 factors predicting inferior EFS. These adverse prognostic factors can be used in clinical practice for predicting outcomes in pediatric HD.<\/jats:p>","DOI":"10.1097\/mph.0000000000001879","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T07:31:40Z","timestamp":1593243100000},"page":"e85-e89","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Outcome and Prognostic Factors of Childhood Hodgkin Disease: Experience From a Single Tertiary Center in Thailand"],"prefix":"10.1097","volume":"43","author":[{"given":"Thirachit","family":"Chotsampancharoen","sequence":"first","affiliation":[{"name":"Department of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shevachut","family":"Chavananon","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pornpun","family":"Sripornsawan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarapee","family":"Duangchu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"McNeil","sequence":"additional","affiliation":[{"name":"Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,6,23]]},"reference":[{"key":"R1-20250804","first-page":"2215","article-title":"Childhood cancer incidence and survival 2003-2005, Thailand: study from the Thai Pediatric Oncology Group","volume":"12","author":"Wiangnon","year":"2011","journal-title":"Asian Pac J Cancer Prev"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"e27428","DOI":"10.1002\/pbc.27428","article-title":"Childhood cancer incidence and survival in Thailand: a comprehensive population-based registry analysis, 1990-2011","volume":"66","author":"Bidwell","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.ejca.2006.05.012","article-title":"Hodgkin\u2019s disease incidence and survival in European children and adolescents (1978-1997): report from the Automated Cancer Information System project","volume":"42","author":"Clavel","year":"2006","journal-title":"Eur J Cancer"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pbc.26278","article-title":"Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin lymphoma: a Report from the Children\u2019s Oncology Group","volume":"64","author":"Schwartz","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1182\/blood-2015-07-641035","article-title":"Hodgkin lymphoma in children and adolescents: improving the therapeutic index","volume":"126","author":"Kelly","year":"2015","journal-title":"Blood"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1200\/JCO.2003.07.124","article-title":"Prognostic factors for children with Hodgkin\u2019s disease treated with combined-modality therapy","volume":"21","author":"Smith","year":"2003","journal-title":"J Clin Oncol"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"e670","DOI":"10.1097\/MD.0000000000000670","article-title":"Hodgkin lymphoma in childhood: clinicopathological features and therapy outcome at 2 centers from a developing country","volume":"94","author":"Sherief","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/pbc.20157","article-title":"Hodgkin\u2019s disease in Indian children: outcome with chemotherapy alone","volume":"46","author":"Arya","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/1097-0142(197808)42:2<787::AID-CNCR2820420251>3.0.CO;2-4","article-title":"Childhood Hodgkin\u2019s disease in Uganda: a ten year experience","volume":"42","author":"Olweny","year":"1978","journal-title":"Cancer"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1008200210674","article-title":"Treatment of childhood Hodgkin\u2019s disease with COPP or COPP-ABV (hybrid) without radiotherapy in Nicaragua","volume":"8","author":"Baez","year":"1997","journal-title":"Ann Oncol"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/(SICI)1096-911X(199901)32:1<18::AID-MPO5>3.0.CO;2-S","article-title":"Hodgkin disease in children: clinicoepidemiologic and viral (Epstein-Barr virus) analyses","volume":"32","author":"Cavdar","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1200\/JCO.1994.12.10.2160","article-title":"ABVD\/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin\u2019s disease: the Stanford experience","volume":"12","author":"Hunger","year":"1994","journal-title":"J Clin Oncol"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1200\/JCO.1997.15.7.2622","article-title":"Does histology influence outcome in childhood Hodgkin\u2019s disease? Results from the United Kingdom Children\u2019s Cancer Study Group","volume":"15","author":"Shankar","year":"1997","journal-title":"J Clin Oncol"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1200\/JCO.1999.17.12.3736","article-title":"High cure rates and reduced long-term toxicity in pediatric Hodgkin\u2019s disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin\u2019s Disease Study Group","volume":"17","author":"Schellong","year":"1999","journal-title":"J Clin Oncol"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejca.2015.09.003","article-title":"The prognostic value of biological markers in paediatric Hodgkin lymphoma","volume":"52","author":"Farruggia","year":"2016","journal-title":"Eur J Cancer"},{"key":"R16-20250804","first-page":"807","article-title":"Significance of splenomegaly in childhood Hodgkin disease","volume":"26","author":"Arya","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"R17-20250804","first-page":"117","article-title":"Thrombocytosis in patients with non-Hodgkin\u2019s lymphomas and Hodgkin\u2019s disease","volume":"98","author":"Dwilewicz-Trojaczek","year":"1997","journal-title":"Pol Arch Med Wewn"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001879","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:12:04Z","timestamp":1754338324000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,23]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001879","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,23]]},"assertion":[{"value":"2020-04-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}